Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133993) titled 'Efficacy and safety of lucotinib phosphate cream combined with mucopolysaccharide polysulfonate cream in the treatment of facial non-segmental vitiligo: A prospective, multicenter, real-world study' on Oct. 9.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First Affiliated Hospital of Chongqing Medical University
Condition:
Vitiligo
Intervention:
Cohort A (Combination Therapy Group. Receiving treatment with 1.5% ruxolitinib phosphate cream in combination with mucopolysaccharide polysulfate cream.):N/A
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollme...